Related Experiment Videos

Maternal hyperphenylalaninemia fetal effects

The Journal of Pediatrics
|February 1, 1984
PubMed

Insights

Maternal hyperphenylalaninemia, a metabolic disorder, can cause birth defects in children. High blood phenylalanine levels in mothers are linked to developmental issues and malformations in their offspring.

Area of Science:

  • Biochemistry
  • Teratology
  • Genetics

Background:

  • Untreated maternal hyperphenylalaninemia is a known risk factor for fetal development.
  • Understanding the teratogenic effects of phenylalanine is crucial for prenatal care.

Purpose of the Study:

  • To investigate the pattern of malformations in offspring exposed to maternal hyperphenylalaninemia.
  • To assess the teratogenic potential of maternal hyperphenylalaninemia and its correlation with phenylalanine levels.

Main Methods:

  • Observational study of 34 children born to 11 mothers with untreated hyperphenylalaninemia.
  • Clinical evaluation of malformations, growth, and neurological function in offspring.
  • Correlation analysis between maternal blood phenylalanine concentrations and observed teratogenic effects.

Main Results:

  • Offspring exhibited significant prenatal and postnatal growth retardation.
  • Microcephaly and central nervous system dysfunction were prevalent.
  • A higher incidence of malformations and a characteristic facial appearance were noted in the children.
  • Teratogenic effects showed variability linked to maternal phenylalanine blood concentrations.

Conclusions:

  • Maternal hyperphenylalaninemia is a significant teratogen, posing risks to fetal development.
  • The severity of developmental abnormalities is associated with maternal phenylalanine levels.
  • This highlights the importance of managing hyperphenylalaninemia during pregnancy to prevent adverse outcomes.

Related Concept Videos